Advertisement

Topics

Companies Related to "Ascendis Pharma Reports Third Quarter 2018 Financial Results" [Most Relevant Company Matches] RSS

04:11 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Ascendis Pharma Reports Third Quarter 2018 Financial Results" found in our extensive corporate database of over 50,000 company records.

Showing "Ascendis Pharma Reports Third Quarter 2018 Financial Results" Companies 1–25 of 3,900+

Relevant

Ascendis Pharma GmbH

Ascendis Pharma A/S is an emerging speciality pharmaceutical company which is creating improved, patentable versions of both currently marketed drugs and high value development-stage opportunities. The company focuses on endocrinology, but also operates within the therapeutic areas of central nervous system and infectious diseases. The company is built upon a novel prodrug technology, TransCon, w...


Yara International

Yara reports strong financial results for the second quarter 2006 and clearly establishes itself as the second largest fertilizer company in Brazil, through the acquisition of the fertilizer and distribution company, Fertibras.Yara has acquired 48.09 percent of the shares in Fertibras for USD 126 million. This represents 99.95 percent of voting shares and Fertibras will therefore be consolidated i...

NeuroTherapeutics Pharma, Inc.

NeuroTherapeutics Pharma is a privately held life sciences company which is focused on the discovery and development of novel therapeutics for patients suffering from CNS disorders. The company is developing compounds that decrease or eliminate aberrant excitatory discharges by working through a new mechanism of action which is unlike that of any marketed ...


Voya Financial, Inc.

Voya Financial, Inc. (NYSE: VOYA), helps Americans plan, invest and protect their savings — to get ready to retire better. Serving the financial needs of approximately 14.3 million individual and institutional customers in the United States, Voya is a Fortune 500 company that had $8.6 billion in revenue in 2017. The company had $543 billion in total a...

Vertex Pharmaceuticals Incorporated

Second Quarter and Six Month Results

Pharma Koreana Ltd.

Pharma Koreana, Korea pharmaceutical news & reports, was established in 1991 and is now Korean leading pharmaceutical business newsletter. For the past years, Pharma Koreana has consistently provided senior executives in the pharmaceutical industry with the inside knowledge they need to compete and win! Readers are subscribers at the pinnacle of their careers as well as the rising stars of tomorro...

Tenet Healthcare Corporation and Health Net, Inc.

This release contains “forward-looking statements” – that is, statements that relate to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as “expect,” “assume,” “anticipate,” â...

Pharma•Logic Development, Inc.

Pharma•Logic is a consulting service to the pharmaceutical, biotechnical and medical device communities. From our base in Northern California, we provide a number of services to our worldwide client base. These include review of preclinical data, strategic planning for clinical development, preparation of the IND, and development of protocols. We assist clients in the writing of final medical re...

The Michigan Cannabis Risk and Financial Association

The Michigan Cannabis Risk and Financial Association (MCRFA) is a financial services company focused on reducing the financial roadblocks associated with Michigan’s legal medical cannabis industry. MCRFA is headquartered in Grand Rapids, Mich. and was founded in 2018. More information on MCRFA can be found at www.mcrfa.com.

FSD Pharma Inc. FSD Pharma Inc.

FSD Pharma is focused on the development of the highest quality indoor grown, pharmaceutical grade cannabis and on the research and development of novel cannabinoid-based treatments for several central nervous system disorders, including chronic pain, fibromyalgia and irritable bowel syndrome. The Company’s phase one growth plan involves the development ...

Alexion Pharmaceuticals, Inc.

Fourth Quarter 2011 Financial Highlights:

Zosano Pharma Corporation

Zosano Pharma Corporation is a clinical stage biopharmaceutical company focused on providing administration of therapeutics to patients using its intracutaneous delivery system, which consists of titanium microneedles coated with drug that can enable rapid systemic administration to patients. The company’s lead product candidate is QtryptaTM (M207), w...

Lincoln Financial Group

Lincoln Financial Group is the marketing name for Lincoln National Corporation (NYSE: LNC) and its affiliates. With headquarters in the Philadelphia region, the companies of Lincoln Financial Group had assets under management of $146 billion as of March 31, 2010. Through its affiliated companies, Lincoln Financial Group offers: annuities; life, group life and disability insurance; 401(k) and 403(b...

AM‐Pharma B.V.

AM‐Pharma is a biopharmaceutical company focused on the preclinical and clinical development of Alkaline Phosphatase as protective treatment of acute kidney injury and inflammatory bowel diseases. AM‐Pharma is based in Bunnik, The Netherlands. Based on the strong results of the Phase II trials with bovine Alkaline Phosphatase in Acute Kidney Injury and ...

AM-Pharma B.V.

AM-Pharma is a biopharmaceutical company focused on the preclinical and clinical development of Alkaline Phosphatase as protective treatment of acute kidney injury and inflammatory bowel diseases. AM-Pharma is based in Bunnik, The Netherlands. Based on the strong results of the Phase II trials with bovine Alkaline Phosphatase in Acute Kidney Injury and a P...

Industry Standard Research

Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise. For more information about our syndicated and custom research offerings, please visit the company’s Web site at www....

Synerkine Pharma B.V.

Synerkine Pharma focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. Synerkine Pharma was founded in 2018 and has licensed the exclusive rights of its lead compound, a fusion protein of IL4 and IL10, from the University Medical Center Utrecht (UMCU), the Netherlands. This fusion protein target...

Sunlight Research, LLC

Sunlight Research(TM) is the premier source for up-to-date Patent Data Analysis, Patent Claims Coverage Reports, Intellectual Property Market Research, Patent Analysis, Non-Practicing Entities Patent Reports and Interactive Freedom To Operate databases. Sunlight provides timely, in-depth and actionable patent analysis reports that are easily accessible and cost effective. Sample reports are avai...

Akzo Nobel

Akzo Nobel is a Global Fortune 500 company and is listed on both the Euronext Amsterdam and NASDAQ stock exchanges. It is also listed on the Dow Jones Sustainability Indexes and the FTSE4Good Index. Based in the Netherlands, we are a multicultural organization serving customers throughout the world with human and animal healthcare products, coatings, and chemicals. We employ around 61,500 people a...

Washington G-2 Reports

An independent news and information service, specializing in diagnostic testing and related medical services, Washington G-2 Reports is the leading market research and publishing firm serving the clinical diagnostic laboratory market in the U.S. Washington G-2 Reports offers timely, accurate reporting and analysis to subscribers in all 50 states, Puerto Rico, Canada, Europe and Asia. In addition...

Akzo Nobel,

Akzo Nobel is a Global Fortune 500 company and is listed on both the euronexy Amsterdam and NASDAQ stock exchanges. It is also listed on the Dow Jones Sustainability Indexes and the FTSE4Good Index. Based in the Netherlands, we are a multicultural organization serving customers throughout the world with human and animal healthcare products, coatings, and chemicals. We employ around 61,500 people a...

PharmaVentures Limited

PharmaVentures is a leading results-driven strategic corporate and business development consultancy assisting pharmaceutical and biotechnology companies worldwide, focusing on all aspects of deal-making including corporate strategy, due diligence and Expert’s Reports, licensing and partnering, valuation and formulation of deal terms, and market research and analysis. PharmaVentures also provide...

Simplify Healthcare

Simplify Healthcare is a rapidly growing technology solutions company that addresses the toughest challenges facing Health Plans in today’s competitive marketplace. Simplify Healthcare was awarded the Deloitte 2018 Technology Fast 500, recognized in the 2018 Inc. 5000 list of America’s fastest-growing private companies, listed as a sample vendor ...

Siren Interactive

Founded in August 2016, Siren is a health technology company and the maker of Neurofabric™, machine-washable, machine-dryable smart textiles. Siren’s first product, Siren Diabetic Socks, are designed to help people with diabetes avoid amputations. Siren was previously named AARP Consumer’s Choice Award winner, 2017 CES TechCrunch Hardware Ba...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and partnering with the research community to efficiently develop and bring medical innovations to market. At H3 Pharma, we highly value Inventors and share their passion for Helping Human Health


More From BioPortfolio on "Ascendis Pharma Reports Third Quarter 2018 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks